Molecular targeted therapy-related life-threatening toxicity in patients with malignancies. A systematic review of published cases

BACKGROUND: Molecular targeted therapy increased overall and disease-free survival in a wide range of malignancies. Although generally well tolerated compared to chemotherapy, molecular targeted therapy may be associated with adverse events requiring ICU admission. Informing clinicians about clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Assoun, Sandra, Lemiale, Virginie, Azoulay, Elie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095151/
https://www.ncbi.nlm.nih.gov/pubmed/31143997
http://dx.doi.org/10.1007/s00134-019-05650-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095151/
https://www.ncbi.nlm.nih.gov/pubmed/31143997
http://dx.doi.org/10.1007/s00134-019-05650-w

Ejemplares similares